Clinical Trial Results: A Study of E7820 in People With Bone Marrow (Myeloid) Cancers [Phase 2]

View source ↗

Summary

Phase 2 trial results for E7820 in myeloid bone marrow cancers have been completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes
• Myelomonocytic Leukemia

Drugs mentioned

• E7820

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Acute Myeloid Leukemia, Myelodysplastic Syndromes | Phase 2 | Status: COMPLETED | Results posted: 2026-06-17